Plasma levels of atrial natriuretic peptide in severe burn injury

Burns

Volumn 26, Issue 5, 2000, Pages 449-453

  Onuoha, Gracey N ^a   Alpar, E Kaya ^a   Gowar, John ^b  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b SELLY OAK HOSPITAL   (United Kingdom)

Author keywords

Atrial natriuretic peptide; Burns; Enzyme immunoassay; Vasoactive intestinal polypeptide

Indexed keywords

ATRIAL NATRIURETIC FACTOR; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BURN; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROLYTE DISTURBANCE; HOMEOSTASIS; HUMAN; LUNG RESISTANCE; MALE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ADULT; AGED; ATRIAL NATRIURETIC FACTOR; BLOOD VOLUME; BODY SURFACE AREA; BURNS; CASE-CONTROL STUDIES; DEHYDRATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; HOMEOSTASIS; HUMANS; LUNG; MALE; MIDDLE AGED; PATIENT ADMISSION; REGIONAL BLOOD FLOW; RENIN-ANGIOTENSIN SYSTEM; RESUSCITATION; SKIN; STATISTICS, NONPARAMETRIC; VASCULAR RESISTANCE; VASOACTIVE INTESTINAL PEPTIDE; WATER-ELECTROLYTE IMBALANCE;

EID: 0342657816     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0305-4179(99)00187-4     Document Type: Article

References (37)

1. de Bold A.J., Borenstein H.B., Veress A.T., et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci. 28:1981;89-94.
2. Brenner B.M., Ballermann B.J., Gunning M.E., Zeidel M.L. Diverse biological actions of atrial natriuretic peptide. Physio. Rev. 70:1990;665-699.
3. Onuoha G.N., Nicholls D.P., Alpar E.K., Ritchie A., Shaw C., Buchannan K. Regulatory peptide in the heart and major vessels of man and mammals. Neuropeptides. 33:1999;165-172.
4. Onuoha G.N., Ritchie A., Nicholls D.P. Distribution of calcitonin gene-related peptide, atrial natriuretic peptide and neuropeptide Y in the rat heart. Cardiology. 90:1998;95-100.
5. Wakabayashi G., Ueda M., Aikawa N., Abe O. Atrial natriuretic polypeptide after burn injury: blood levels and physiological role in rats. Burns. 16:1990;169-175.
6. Braquet M., Carsin H., Guilbaud J., et al. Plasma atrial natriuretic peptide in severe thermal injury. Lancet. ii:1986;456.
7. Bonow R.O. New insight into the cardiac natriuretic peptides. Circulation. 93:1996;1946-1950.
8. Onuoha G.N., Shaw C., Nicholls D.P. Extraction of human alpha atrial natriuretic peptide and its physiological validation. Int. J. Cardiol. 65:1998;23-31.
9. Nugent A.-M., Onuoha G.N., McEneaney D.J., et al. Variable patterns of atrial natriuretic peptide secretion in man. Eur. J. Clin. Invest. 24:1994;267-274.
10. Baranowska B. Role of pancreatic peptides-neuropeptide Y, polypeptide YY and neurotensin, vasoactive intestine peptide and substance P in the body. Polski Yygodnik Lekarski. 45:1990;185-188.
11. Konig W. Peptide and hormones structure, regulation, activity. 1993;155-158 VCH Weinheim, New York.
12. Bjorck S., Fahrenkrug J., Jivegard L., Svanvik J. Release of immunoreactive vasoactive intestinal peptide (VIP) from gallbladder in response to vagal stimulation. Acta Physiol. Scand. 128:1986;639-642.
13. Iwanaga T., Kitamura S., Hirose T., Said S.I. Vasoactive intestine peptide (VIP) protects against acid-induced acute lung injury in isolated perfused rat lungs. Jpn. J. Thorac. Dis. 27:1989;789-795.
14. Said S.I., Mutt V. Potent peripheral and splenchnic vasodilator peptide from normal gut. Nature (London). 225:1970;863-864.
15. Wei C.M., Heutlein D.M., Perrella M.A., Lerman A., et al. Natriuretic peptide system in human heart failure. Circulation. 88:1993;1004-1009.
16. Sonnenberg H., Verress A.T. Cellular mechanism of release of atrial natriuretic factor. Bio. Biophys. Res. Commun. 124:1984;443-449.
17. Opstad P.K. The plasma vasoactive intestinal peptide (VIP response to exercise is increased after prolonged strain, sleep and energy deficiency and extinguished by glucose infusion. Peptides. 8:1987;175-178.
18. Patterson D.R., Carrigan L., Robinson R., et al. Post-traumatic stress disorder in hospitalised patients with burn injuries. J. Burn Care Rehab. 11:1990;181-184.
19. Taal L.A., Faber A.W. Burn injuries, pain and distress: exploring the role of stress symptomatology. Burns. 23:1997;288-290.
20. Linz W., Albus U., Wiemer G., Scholkens B.A., Konig W. Atriopeptin III induces endothelium-independent relaxation and increases cGMP levels in rabbit aorta. Klin. Wochenschr. 64:1986;27-30.
21. Itoh K., Goseki N., Endo M., Marumo F. Increased plasma atrial natriuretic peptide and endothelin concentrations after surgery in patients with esophageal and gastric cancer. Bull. Tokyo Med. Dental Univ. 43:1996;45-51.
22. Fontana F., Bernardi P., Pich E.M., Boschi S., De Iasio R., Spampinato S. Endogenous opioid peptides and mental stress in congestive heart failure patients. Peptides. 19:1998;21-26.
23. Horky K., Gutkowska J., Garcia R., Thibault G., Genest J., Cantin M. Effect on different anaesthetics on immunoreactive atrial natriuretic factor concentrations in rat plasma. Biochem. Biophys. Res. Comm. 129:1985;651-657.
24. Kuchan M.J., Frangos J.A. Shear stress regulates endothelin-1 release via protein kinase C and cGMP in cultured endothelial cells. Am. J. Physiol. 264:1995;H150-H156.
25. Davies J.W.L. Body content of water and electrolytes. Physiological Responses to Burning Injury. 1982;193 Academic Press, London.
26. Balogh D., Benzer A., Hackl J.M., et al. Sodium balance and osmolarity in burn patients. Intensive Care Med. 12:1986;100-103.
27. Lang R.E., Tholken H., Ganten D., et al. Atrial natriuretic factor: a circulating hormone stimulated by volume loading. Nature. 314:1985;264-266.
28. Baertschi A.J., Jiao J., Calson D.E., et al. Neural control of ANF release in hypoxia and pulmonary hypertension. Am. J. Physiol. 259:1990;H735-H744.
29. Zapol W.M., Sinder M.T. Pulmonary hypertension in severe acute respiratory failure. N. Engl. J. Med. 296:1977;476-480.
30. Asai J., Nakazato M., Toshimori H., et al. Presence of atrial natriuretic polypeptide in the pulmonary vein and vena cava. Biochem. Biophys. Res. Commun. 146:1987;1465-1470.
31. Sakamoto M., Nakao K., Morii N., et al. The lung as a possible target organ for atrial natriuretic polypeptide secreted from the heart. Biochem. Biophys. Res. Commun. 135:1986;515-520.
32. Gutkowska J., Nemer M., Sole M.J., et al. Lung is an important source of atrial natriuretic factor in experimental cardiomyopathy. J. Clin. Invest. 83:1989;1500-1504.
33. Bianchi C., Gutkowska J., Thibault G., et al. Radioautographic localization of 125I-atrial natriuretic factor (ANF) in rat tissues. Histochemistry. 82:1985;441-452.
34. Hollister A.S., Rodeheffer R.J., White F.J., et al. Clearance of atrial natriuretic factor by lung, liver, and kidney in human subjects and the dog. J. Clin. Invest. 83:1989;623-628.
35. Edwards B.S., Zimmerman R.S., Schwab T.R., et al. Atrial stretch not pressure is the principal determinant controlling the acute release of atrial; natriuretic peptide. Circ. Res. 62:1988;191-195.
36. Schunkert H., Dzau V.J., Tang S.S., et al. Increased rat cardiac angiotensin converting enzyme activity and mRNA expression ure overload hyperthrophy: effects on coronary resistance, contractility, and relaxation. J. Clin. Invest. 86:1990;1913-1920.
37. Cuocolo A., Sax F.L., Brush J.E., et al. Left ventricular hyperthrophy and impared diastolic filling in essential hypertension: diastolic mechanisms for systolic dysfunction during exercise. Circulation. 81:1990;978-986.